FDA won't comment on status of Emergency Use Authorizations for two antibody treatments

The US Food and Drug Administration told CNN Thursday morning that the agency doesn’t have any comments on the applications for Emergency Use Authorizations for Eli Lilly and Regeneron antibody treatments.
The coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.

FDA issues emergency use authorization for bebtelovimab - The

FDA announces Evusheld is not currently authorized for emergency

US allows 1st emergency use of a COVID-19 antibody drug

FDA won't comment on status of Emergency Use Authorizations for

Federal Register :: Authorizations of Emergency Use of Certain

FDA Meeting on COVID Vaccine for Children

Assessment of unvaccinated and vaccinated patients with

Federal Register :: Authorizations of Emergency Use of Certain

Moderna asks the F.D.A. to authorize its vaccine for children

Federal Register :: Authorizations of Emergency Use of Certain

FDA Revokes Authorization for the Only Remaining COVID-19